跳至主要内容
临床试验/NL-OMON37275
NL-OMON37275已完成不适用

Determination and/or following of High on-aspirin platelet reactivity (HARP) in CABG patients using the Verifynow Aspirin. - HAPR in CABG patients

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 21 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Elective pre-CABG patients (with during the CABG use of Heartlung machine)
  • Use of preoperative Aspirin

排除标准

  • Use of other platelets aggregation inhibiting medicines, NSAID'S, GPIIb/IIIa receptor antagonists, anticoagulants and/or heparines. (e.g., Dipyridamole, Acenocoumarol, Nadroparine, Plavix, etc.)
  • Under-age patients and minors.
  • Insufficient mastery of the Dutch or English to get wel informed.
  • Intolerance to aspirin.
  • Coagulation abnormalities, congenital platelets abnormalities and/or medication (non-aspirin) induced platelet abnormality

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验